| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.37 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.34 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |